These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31754448)

  • 1. Hepatitis B and HIV-1 2019 IAS Cure Forum: lessons and benefits from interdisciplinary research.
    Paximadis M; Perez Patrigeon S; Rajasuriar R; Tatoud R; Scully E; Arbuthnot P
    J Virus Erad; 2019 Nov; 5(4):234-244. PubMed ID: 31754448
    [No Abstract]   [Full Text] [Related]  

  • 2. Converging roads: the latest science from the 2017 IAS HIV Cure and Cancer Forum.
    Martin GE; Alcami J; Spano JP; Ross AL
    J Virus Erad; 2017 Oct; 3(4):236-241. PubMed ID: 29057089
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of the Hepatitis B Virus/HIV-Coinfected Patient.
    Sherman KE
    Top Antivir Med; 2015; 23(3):111-4. PubMed ID: 26518394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Hepatitis C during Pregnancy-Weighing the Risks and Benefits in Contrast to HIV.
    Barritt AS; Jhaveri R
    Curr HIV/AIDS Rep; 2018 Apr; 15(2):155-161. PubMed ID: 29470782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-step pace towards a cure for HIV: kick, kill, and contain.
    López M
    AIDS Rev; 2013; 15(3):190-1. PubMed ID: 24002204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. For love and money: the need to rethink benefits in HIV cure studies.
    Largent E
    J Med Ethics; 2017 Feb; 43(2):96-99. PubMed ID: 27193021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobilising a global response to hepatitis: Lessons learned from the HIV movement.
    Taaffe J; Wilson D
    Glob Public Health; 2018 Apr; 13(4):473-488. PubMed ID: 27748158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cure at IAS 2013.
    Berry J
    Posit Aware; 2013; 25(6):22-3. PubMed ID: 24847583
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to Commentary: "Are HIV-Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Healthy?".
    Dubé K; Sylla L; Dee L
    J Empir Res Hum Res Ethics; 2018 Feb; 13(1):23-25. PubMed ID: 29179626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The As and Bs of HIV and Hepatitis Co-Infection.
    Wooten D; Karris MY
    Trop Med Infect Dis; 2019 Mar; 4(2):. PubMed ID: 30934708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of HIV cure-related trials: the challenges for physicians and people living with HIV (ANRS-APSEC).
    Preau M; Doumergue M; Protiere C; Goujard C; Mora M; Meyer L; Lelievre JD; Raffi F; Spire B; Lambotte O; Suzan-Monti M
    AIDS Care; 2018 Jul; 30(7):914-920. PubMed ID: 29347826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and AIDS and the promise for their control by vaccines.
    Hilleman MR
    Vaccine; 1988 Apr; 6(2):175-9. PubMed ID: 3291455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV and HCV Epidemics: Lessons for Lawyers and Policymakers.
    Kirby M
    J Law Med; 2019 Apr; 26(3):583-594. PubMed ID: 30958651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Status and progress in chronic hepatitis B cure].
    Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):561-564. PubMed ID: 30317785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The latest science from the IAS Towards an HIV Cure Symposium: 16-17 July 2016, Durban, South Africa.
    Mann J; Pasternak AO; Chahroudi A; Singh JA; Ross AL
    J Virus Erad; 2016 Oct; 2(4):235-241. PubMed ID: 27781107
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV Transmission and Injection Drug Use: Lessons From the Indiana Outbreak.
    Janowicz DM
    Top Antivir Med; 2016; 24(2):90-92. PubMed ID: 27841978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expert consensus on clinical cure (functional cure) of chronic hepatitis B].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):594-603. PubMed ID: 31594076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapy.
    Li MH; Yi W; Zhang L; Lu Y; Lu HH; Shen G; Wu SL; Hao HX; Gao YJ; Chang M; Liu RY; Hu LP; Cao WH; Chen QQ; Li JN; Wan G; Xie Y
    J Viral Hepat; 2019 Jul; 26 Suppl 1():32-41. PubMed ID: 31380582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meeting notes from the 3rd IAS Conference. Advances in the treatment of hepatitis/HIV coinfection.
    Sax PE
    AIDS Clin Care; 2005 Oct; 17(10):97-8. PubMed ID: 16276592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the socioeconomic determinants of adolescent health: experiences from the WHO/HBSC Forum 2007.
    Koller T; Morgan A; Guerreiro A; Currie C; Ziglio E;
    Int J Public Health; 2009 Sep; 54 Suppl 2():278-84. PubMed ID: 19639252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.